Literature DB >> 22143534

Accumulation of the SET protein in HEK293T cells and mild oxidative stress: cell survival or death signaling.

Andréia M Leopoldino1, Cristiane H Squarize, Cristiana B Garcia, Luciana O Almeida, Cezar R Pestana, Ana C M Polizello, Sérgio A Uyemura, Eloiza H Tajara, J Silvio Gutkind, Carlos Curti.   

Abstract

SET protein (I2PP2A) is an inhibitor of PP2A, which regulates the phosphorylated Akt (protein kinase B) levels. We assessed the effects of SET overexpression in HEK293T cells, both in the presence and the absence of mild oxidative stress induced by 50 μM tert-butyl hydroperoxide. Immunoblotting assays demonstrated that SET accumulated in HEK293T cells and increased the levels of phosphorylated Akt and PTEN; in addition, SET decreased glutathione antioxidant defense of cell and increased expression of genes encoding antioxidant defense proteins. Immunofluorescence analysis demonstrated that accumulated SET was equally distributed in cytoplasm and nucleus; however, in cells that had been exposed to oxidative stress, SET was found in large aggregates in the cytoplasm. SET accumulation in HEK293T cells correlated with inhibition of basal apoptosis as evidenced by a decrease in annexin V staining and activity of caspases; under mild oxidative stress, SET accumulation correlated with caspase-independent cell death, as evidenced by increased PI and annexin V/PI double staining. The results suggest that accumulated SET could act via Akt/PTEN either as cell survival signal or as oxidative stress sensor for cell death.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22143534     DOI: 10.1007/s11010-011-1158-x

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  51 in total

1.  Phosphorylation of the PTEN tail regulates protein stability and function.

Authors:  F Vazquez; S Ramaswamy; N Nakamura; W R Sellers
Journal:  Mol Cell Biol       Date:  2000-07       Impact factor: 4.272

2.  I1PP2A and I2PP2A. Two potent protein phosphatase 2A-specific inhibitor proteins.

Authors:  M Li; Z Damuni
Journal:  Methods Mol Biol       Date:  1998

3.  Oxidative stress induced-metabolic imbalance, mitochondrial failure, and cellular hypoperfusion as primary pathogenetic factors for the development of Alzheimer disease which can be used as a alternate and successful drug treatment strategy: past, present and future.

Authors:  Gjumrakch Aliev
Journal:  CNS Neurol Disord Drug Targets       Date:  2011-03       Impact factor: 4.388

Review 4.  PI3K: downstream AKTion blocks apoptosis.

Authors:  T F Franke; D R Kaplan; L C Cantley
Journal:  Cell       Date:  1997-02-21       Impact factor: 41.582

5.  Nuclear PTEN regulates the APC-CDH1 tumor-suppressive complex in a phosphatase-independent manner.

Authors:  Min Sup Song; Arkaitz Carracedo; Leonardo Salmena; Su Jung Song; Ainara Egia; Marcos Malumbres; Pier Paolo Pandolfi
Journal:  Cell       Date:  2011-01-21       Impact factor: 41.582

6.  The redox protein thioredoxin-1 (Trx-1) increases hypoxia-inducible factor 1alpha protein expression: Trx-1 overexpression results in increased vascular endothelial growth factor production and enhanced tumor angiogenesis.

Authors:  Sarah J Welsh; William T Bellamy; Margaret M Briehl; Garth Powis
Journal:  Cancer Res       Date:  2002-09-01       Impact factor: 12.701

Review 7.  Is Akt the "Warburg kinase"?-Akt-energy metabolism interactions and oncogenesis.

Authors:  R Brooks Robey; Nissim Hay
Journal:  Semin Cancer Biol       Date:  2008-12-14       Impact factor: 15.707

Review 8.  ROS stress in cancer cells and therapeutic implications.

Authors:  Helene Pelicano; Dennis Carney; Peng Huang
Journal:  Drug Resist Updat       Date:  2004-04       Impact factor: 18.500

9.  Expression of SET, an inhibitor of protein phosphatase 2A, in renal development and Wilms' tumor.

Authors:  S G Carlson; E Eng; E G Kim; E J Perlman; T D Copeland; B J Ballermann
Journal:  J Am Soc Nephrol       Date:  1998-10       Impact factor: 10.121

10.  PTEN inhibits BMI1 function independently of its phosphatase activity.

Authors:  Catherine Fan; Lizhi He; Anil Kapoor; Adrian P Rybak; Jason De Melo; Jean-Claude Cutz; Damu Tang
Journal:  Mol Cancer       Date:  2009-11-10       Impact factor: 27.401

View more
  15 in total

1.  Autophagy and KRT8/keratin 8 protect degeneration of retinal pigment epithelium under oxidative stress.

Authors:  Ahruem Baek; Soojin Yoon; Jean Kim; Yu Mi Baek; Hanna Park; Daehan Lim; Hyewon Chung; Dong-Eun Kim
Journal:  Autophagy       Date:  2017-01-03       Impact factor: 16.016

2.  Upregulation of the oncoprotein SET determines poor clinical outcomes in hepatocellular carcinoma and shows therapeutic potential.

Authors:  M-H Hung; Y-L Chen; P-Y Chu; C-T Shih; H-C Yu; W-T Tai; C-W Shiau; K-F Chen
Journal:  Oncogene       Date:  2016-02-15       Impact factor: 9.867

3.  Putative Roles of SETBP1 Dosage on the SET Oncogene to Affect Brain Development.

Authors:  Lilit Antonyan; Carl Ernst
Journal:  Front Neurosci       Date:  2022-05-24       Impact factor: 5.152

4.  Evaluation of 9-cis retinoic acid and mitotane as antitumoral agents in an adrenocortical xenograft model.

Authors:  Zoltán Nagy; Kornélia Baghy; Éva Hunyadi-Gulyás; Tamás Micsik; Gábor Nyírő; Gergely Rácz; Henriett Butz; Pál Perge; Ilona Kovalszky; Katalin F Medzihradszky; Károly Rácz; Attila Patócs; Peter Igaz
Journal:  Am J Cancer Res       Date:  2015-11-15       Impact factor: 6.166

5.  Expression of set is downregulated by rapamycin in human colorectal cancer cells.

Authors:  Xiaoxia Wen; Yao Chen
Journal:  Biomed Rep       Date:  2013-07-11

Review 6.  The Basic Biology of PP2A in Hematologic Cells and Malignancies.

Authors:  Dorien Haesen; Ward Sents; Katleen Lemaire; Yana Hoorne; Veerle Janssens
Journal:  Front Oncol       Date:  2014-12-11       Impact factor: 6.244

7.  Development and identification of Set transgenic mice.

Authors:  Siliang Xu; Xiaoqiang Liu; Lingling Gao; Boqun Xu; Jianmin Li; Chao Gao; Yugui Cui; Jiayin Liu
Journal:  Exp Ther Med       Date:  2017-12-11       Impact factor: 2.447

8.  Crosstalk between hnRNP K and SET in ATRA-induced differentiation in acute promyelocytic leukemia.

Authors:  Karina Stringhetta Padovani; Renata Nishida Goto; Lais Brigliadori Fugio; Cristiana Bernadelli Garcia; Vani Maria Alves; Maria Sol Brassesco; Lewis Joel Greene; Eduardo Magalhães Rego; Andréia Machado Leopoldino
Journal:  FEBS Open Bio       Date:  2021-06-17       Impact factor: 2.693

9.  Stable SET knockdown in head and neck squamous cell carcinoma promotes cell invasion and the mesenchymal-like phenotype in vitro, as well as necrosis, cisplatin sensitivity and lymph node metastasis in xenograft tumor models.

Authors:  Lays M Sobral; Lucas O Sousa; Ricardo D Coletta; Hamilton Cabral; Lewis J Greene; Eloiza H Tajara; J Silvio Gutkind; Carlos Curti; Andréia M Leopoldino
Journal:  Mol Cancer       Date:  2014-02-20       Impact factor: 27.401

10.  SET antagonist enhances the chemosensitivity of non-small cell lung cancer cells by reactivating protein phosphatase 2A.

Authors:  Man-Hsin Hung; Cheng-Yi Wang; Yen-Lin Chen; Pei-Yi Chu; Yung-Jen Hsiao; Wei-Tien Tai; Ting-Ting Chao; Hui-Chuan Yu; Chung-Wai Shiau; Kuen-Feng Chen
Journal:  Oncotarget       Date:  2016-01-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.